Malaria –
**Core Concept**
The question pertains to the pathophysiology and treatment of malaria, a vector-borne infectious disease caused by Plasmodium parasites transmitted through the bite of an infected Anopheles mosquito. The correct answer choice involves the understanding of the mechanism of action of a specific antimalarial drug.
**Why the Correct Answer is Right**
The correct answer is related to the mechanism of action of atovaquone, a medication used to treat malaria. Atovaquone works by inhibiting the electron transport chain in the mitochondria of the parasite, specifically targeting the cytochrome bc1 complex. This disruption prevents the parasite from generating energy, ultimately leading to its death. Atovaquone is often used in combination with proguanil for the treatment of uncomplicated malaria.
**Why Each Wrong Option is Incorrect**
**Option A:** This option might be incorrect because it does not accurately describe the mechanism of action of atovaquone or another commonly used antimalarial medication.
**Option B:** This option might be incorrect because it does not accurately describe the mechanism of action of atovaquone or another commonly used antimalarial medication.
**Option C:** This option might be incorrect because it does not accurately describe the mechanism of action of atovaquone or another commonly used antimalarial medication.
**Option D:** This option might be incorrect because it does not accurately describe the mechanism of action of atovaquone or another commonly used antimalarial medication.
**Clinical Pearl / High-Yield Fact**
Atovaquone is often used in combination with proguanil because this combination has been shown to be more effective against certain strains of Plasmodium falciparum than either medication alone. This combination is a key consideration in the treatment of malaria, particularly in areas where resistance to other antimalarial medications is common.
**Correct Answer: C. Atovaquone works by inhibiting the electron transport chain in the mitochondria of the parasite, specifically targeting the cytochrome bc1 complex.**